Clinical Trial: A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804615) titled 'A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy' on Aug. 31.

Brief Summary: Vista PD is a randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, and tolerability of VIM0423 in adults with Parkinson's disease tremor insufficiently responsive to dopaminergic therapy.

The main objectives of this clinical trial are to determine the following:

* Does VIM0423 therapy improve tremor symptoms in adults with Parkinson's disease?

* Is VIM0423 well tolerated in individuals with Parkinsons's d...